LENS

ZEISS Single Vision MyoVision™

The innovative spectacle lens enabling
a reduction of myopia progression by an average of 30%
in Asian children between 6 and 12 years with a history of parental myopia.*

MyoVision™ is a ZEISS single vision lens design with the innovative “Peripheral Vision Management” technology. It has been invented and designed in collaboration with Vision CRC and marketed exclusively by ZEISS. MyoVision™ by ZEISS was developed following research that demonstrates the link between peripheral retinal image blur and myopia progression. MyoVision™ has been designed to provide sharp foveal vision while managing peripheral imaging through a unique and novel lens design.

A 12-month wearer efficacy trial amongst 210 Chinese school children resulted in a reduction in the progression of myopia by an average of 30% in a subgroup of 19 younger children (6 to 12 years old) with at least one myopic parent.*
This is statistically significant.

The benefits for the wearer

  • Deliver clear and sharply focused vision
  • Initial research indicates an effect of sending a signal to the eye to reduce the progression of eye elongation
  • Offer good comfort through thin and light lenses
  • Provides excellent adaptability, cosmetic advantages and wearability

* Clinical trials of 210 Chinese children between the ages of 6 and 16 years old over a period of 12 month. 50 children wearing MyoVision™ lenses and 50 children standard single vision lenses. Result is achieved in a subgroup (19 children out of 50 wearing MyoVision™ lenses) between the ages of 6 to 12 years old and with at least one myopic parent. Sankaridurg et al, Optometry and Vision Science, Vol 87, No. 9, September 2012; pp631-641.

without
https://orraoptometrist.com/wp-content/themes/rayko/
https://orraoptometrist.com/
#EDB44D
style1
default
Loading posts...
/home/www/virtual/orraoptometrist.com/htdocs/
#
off
none
loading
#
Sort Gallery
on
off
off
off
X